Anupam Rasayan India Ltd recorded volume of 56.26 lakh shares by 14:14 IST on NSE, representing a 18.25 times surge over the two-week average daily volume of 3.08 lakh shares. The stock lost 2.34% to ₹1,179.40 during the trading session, showing mixed investor sentiment despite the high trading volumes. This represents a significant increase from the 4.65 lakh shares traded in the previous session, indicating heightened investor interest following recent developments. The surge in volumes comes amid the company's recent NCD allotment and ongoing market reactions to the debt restructuring.
Anupam Rasayan India Ltd has allotted ₹160 crore worth of NCDs to Aditya Birla Capital Limited on a private placement basis, with the proceeds intended for repayment of existing debt facilities, investment in group companies, and general corporate purposes. As reported by CNBC TV18, promoter Anand Sureshbhai Desai pledged 31.5 lakh shares to secure the debt, with the allotment made at par and the debentures carrying a coupon rate of 10.25% per annum with a tenure of 13 months. The issuance was approved by the board on May 23, 2026, and executed by the Executive Committee on May 26, 2026, with Catalyst Trusteeship Limited appointed as the debenture trustee.
Earlier this month, Anupam Rasayan secured a chemical supply contract with a global industrial major, paving the way for a long-term six-year partnership. While the company did not name the company, it confirmed it was awarded the order by a major specialty metal manufacturer headquartered in the US. The company expects consolidated revenue growth to be more than 30% this fiscal, up from its previous guidance of 20-25%. Deputy CFO Vishal Thakkar told CNBC TV18 that the growth is largely volume-driven, with the pharma and polymer businesses continuing to support performance.
The company reported strong financial results for the June quarter, with profit increasing 14% to ₹38.6 crore from ₹34 crore in the previous year. Revenue grew 35% to ₹655 crore from ₹485.8 crore. However, EBITDA increased 31% to ₹162.4 crore from ₹124.3 crore, but the margin contracted to 25.8% from 25.6% in the year-ago period. Following the NCD allotment, the company will redeem the debentures in two tranches: ₹99,500 of principal amount plus accrued interest on September 21, 2026, and the residual principal of ₹500 per NCD with accrued interest upon final maturity on June 26, 2027. At the end of the June quarter, promoter entities held 59.07% stake while public shareholders held 40.83% in the company.
The stock has declined 4.4% in the past month and is down 10.4% this year, reflecting investor concerns about the company's debt structure and ownership changes. Following the NCD announcement and block deals, the stock was trading 1.6% lower at ₹1,188 apiece at 10.03 am. The immediate market reaction to the high coupon rate of 10.25% and the significant redemption tranche scheduled for September 2026, just four months after allotment, has contributed to the continued pressure on the stock price. The security package includes a minimum security cover requirement of 250% to be maintained at all times.
